Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
After finishing at $46.37 in the prior trading day, Bruker Corp (NASDAQ: BRKR) closed at $45.13, down -2.67%. In other words, the price has decreased by -$2.67 from its previous closing price. On the day, 1.68 million shares were traded. BRKR stock price reached its highest trading level at $47.8999 during the session, while it also had its lowest trading level at $45.0.
Ratios:
Our goal is to gain a better understanding of BRKR by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.91 and its Current Ratio is at 1.85. In the meantime, Its Debt-to-Equity ratio is 0.83 whereas as Long-Term Debt/Eq ratio is at 0.82.
On December 09, 2025, Goldman started tracking the stock assigning a Sell rating and target price of $40.
On November 20, 2025, Rothschild & Co Redburn started tracking the stock assigning a Buy rating and target price of $60.Rothschild & Co Redburn initiated its Buy rating on November 20, 2025, with a $60 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 01 ’25 when PACKER RICHARD A sold 5,028 shares for $48.38 per share. The transaction valued at 243,230 led to the insider holds 89,174 shares of the business.
RICHARD A PACKER bought 5,028 shares of BRKR for $243,230 on Dec 01 ’25. On Nov 06 ’25, another insider, ORNELL JOHN A, who serves as the Director of the company, sold 6,233 shares for $39.00 each. As a result, the insider received 243,087 and left with 35,212 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BRKR now has a Market Capitalization of 6857104384 and an Enterprise Value of 8672004096. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 41.35. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.99 while its Price-to-Book (P/B) ratio in mrq is 2.81. Its current Enterprise Value per Revenue stands at 2.522 whereas that against EBITDA is 14.824.
Stock Price History:
The Beta on a monthly basis for BRKR is 1.17, which has changed by -0.1890521 over the last 52 weeks, in comparison to a change of 0.13613915 over the same period for the S&P500. Over the past 52 weeks, BRKR has reached a high of $64.64, while it has fallen to a 52-week low of $28.53. The 50-Day Moving Average of the stock is 8.86%, while the 200-Day Moving Average is calculated to be 15.45%.
Shares Statistics:
The stock has traded on average 3.13M shares per day over the past 3-months and 2264320 shares per day over the last 10 days, according to various share statistics. A total of 151.39M shares are outstanding, with a floating share count of 103.19M. Insiders hold about 32.08% of the company’s shares, while institutions hold 89.00% stake in the company. Shares short for BRKR as of 1764288000 were 13704909 with a Short Ratio of 4.38, compared to 1761868800 on 13850895. Therefore, it implies a Short% of Shares Outstanding of 13704909 and a Short% of Float of 19.42.
Dividends & Splits
In the trailing 12 months, BRKR’s forward annual dividend rate was 0.2, compared to 0.20 this year. Against a Trailing Annual Dividend Yield of 0.004313133. The stock’s 5-year Average Dividend Yield is 0.31.
Earnings Estimates
. The current rating of Bruker Corp (BRKR) reflects the combined expertise of 13.0 analysts actively engaged in assessing its market performance.The consensus estimate for the next quarter is $0.42, with high estimates of $0.61 and low estimates of $0.27.
Analysts are recommending an EPS of between $1.9 and $1.86 for the fiscal current year, implying an average EPS of $1.88. EPS for the following year is $2.15, with 15.0 analysts recommending between $2.44 and $2.0.
Revenue Estimates
12 analysts predict $958.3M in revenue for. The current quarter. It ranges from a high estimate of $966.5M to a low estimate of $952.51M. As of. The current estimate, Bruker Corp’s year-ago sales were $979.6MFor the next quarter, 12 analysts are estimating revenue of $803.82M. There is a high estimate of $828.43M for the next quarter, whereas the lowest estimate is $770M.
A total of 13 analysts have provided revenue estimates for BRKR’s current fiscal year. The highest revenue estimate was $3.43B, while the lowest revenue estimate was $3.41B, resulting in an average revenue estimate of $3.42B. In the same quarter a year ago, actual revenue was $3.37BBased on 13 analysts’ estimates, the company’s revenue will be $3.47B in the next fiscal year. The high estimate is $3.55B and the low estimate is $3.43B.
